HomeGeneticsConditionMultiple familial trichoepithelioma
Back to Condition
Multiple familial trichoepithelioma
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

Multiple familial trichoepithelioma

Multiple familial trichoepithelioma is a rare genetic condition characterized by the development of numerous noncancerous skin tumors arising from hair follicles, typically beginning in childhood or adolescence.

Overview

Multiple familial trichoepithelioma is a condition involving multiple skin tumors that develop from structures associated with the skin (skin appendages), such as hair follicles and sweat glands. People with multiple familial trichoepithelioma typically develop large numbers of smooth, round tumors called trichoepitheliomas, which arise from hair follicles. Trichoepitheliomas are generally noncancerous (benign) but occasionally develop into a type of skin cancer.

Individuals with multiple familial trichoepithelioma occasionally also develop other types of tumors, including growths called spiradenomas and cylindromas. Spiradenomas develop in sweat glands. The origin of cylindromas has been unclear; while previously thought to derive from sweat glands, they are now generally believed to begin in hair follicles. Affected individuals are also at increased risk of developing tumors in tissues other than skin appendages, particularly benign or malignant tumors of the salivary glands.

Symptoms and Progression

People with multiple familial trichoepithelioma typically begin developing tumors during childhood or adolescence. The progression and impact of these tumors include:

  • Location: The tumors mostly appear on the face, especially in the folds in the skin between the nose and lips (nasolabial folds, sometimes called smile lines), but may also occur on the neck, scalp, or trunk.
  • Growth: They may grow larger and increase in number over time.
  • Functional Impact: In severe cases, the tumors may get in the way of the eyes, ears, nose, or mouth and affect vision, hearing, or other functions.
  • Psychological Impact: The growths can be disfiguring and may contribute to depression or other psychological problems.
  • Gender Differences: For reasons that are unclear, females with multiple familial trichoepithelioma are often more severely affected than males.

Frequency

Multiple familial trichoepithelioma is a rare disorder; its prevalence is unknown.

Causes and Genetics

Multiple familial trichoepithelioma can be caused by mutations in the CYLD gene. This gene provides instructions for making a protein that helps regulate nuclear factor-kappa-B. Nuclear factor-kappa-B is a group of related proteins that help protect cells from self-destruction (apoptosis) in response to certain signals. In regulating the action of nuclear factor-kappa-B, the CYLD protein allows cells to respond properly to signals to self-destruct when appropriate, such as when the cells become abnormal. By this mechanism, the CYLD protein acts as a tumor suppressor, which means that it helps prevent cells from growing and dividing too fast or in an uncontrolled way.

The genetic development of the condition involves the following process:

  • People with CYLD-related multiple familial trichoepithelioma are born with a mutation in one of the two copies of the CYLD gene in each cell. This mutation prevents the cell from making functional CYLD protein from the altered copy of the gene.
  • Enough protein is usually produced from the other, normal copy of the gene to regulate cell growth effectively.
  • For tumors to develop, a second mutation or deletion of genetic material involving the other copy of the CYLD gene must occur in certain cells during a person's lifetime.
  • When both copies of the CYLD gene are mutated in a particular cell, that cell cannot produce any functional CYLD protein. The loss of this protein allows the cell to grow and divide in an uncontrolled way to form a tumor.
  • In people with multiple familial trichoepithelioma, a second CYLD mutation typically occurs in multiple cells over an affected person's lifetime, leading to the growth of skin appendage tumors

Frequently Asked Questions

Treatment for trichoepitheliomas is typically focused on managing symptoms and improving appearance or function. Options include surgical removal, laser therapy, cryotherapy (freezing), or electrosurgery. The choice of treatment depends on the size, location, and number of tumors, as well as their impact on the individual. Recurrence after treatment is common, and new tumors may continue to develop.
While trichoepitheliomas are generally benign, they can occasionally transform into a type of skin cancer. Warning signs to look for include rapid growth, changes in color, bleeding, or ulceration of a lesion. Individuals with multiple familial trichoepithelioma should have regular skin examinations by a dermatologist, typically annually or more frequently if there are concerning changes or a history of atypical lesions.
Individuals with multiple familial trichoepithelioma are at an increased risk of developing other types of skin appendage tumors, such as spiradenomas and cylindromas. They also have a heightened risk for both benign and malignant tumors in other tissues, particularly in the salivary glands. Therefore, regular comprehensive medical check-ups, beyond just skin examinations, are important to monitor for these additional potential growths.
The visible nature of the tumors, especially on the face, can lead to significant psychological distress, including anxiety, depression, and social isolation. Support can come from mental health professionals, such as therapists or counselors, who can help individuals cope with body image concerns and develop coping strategies. Connecting with patient support groups can also provide a sense of community and shared understanding.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA